[EXPERT REACTION] What is the difference between VOI & VOC?

Recently, Malaysia has been recording an increased number of COVID-19 cases categorised by either the Variant of Concern (VOC) or Variant of Interest (VOI). VOCs or VOIs are mutant forms of the COVID virus (SARS-CoV-2), which are more virulent and infectious than its predecessor Wuhan strain. Dr Liyana explains the difference between VOI and VOCs in Malaysia.

[OPINION] Opportunity Knocks: How We Can Turn the Tide of Covid-19 Transmission in Malaysia

The 3rd iteration of the Movement Control Order (MCO) has just been intensified. It is as such an opportune time for us to take cognizance of our control measures so far and in doing so realign our response measures to COVID-19. Dr Dhesi BR in his opinion piece presents six key priority areas within which said realignment must take place.

[FEATURE ARTICLE] In Conversation with the 2020 Mahathir Science Award Recipient

This year, the Mahathir Science Award – the most prestigious science award for tropical sciences was presented to Professor Sir Alimuddin Zumla of University College London, in recognition of his exceptional, globally acknowledged research in infectious diseases which is relevant to the development and enhancement of health policy.

[MEDIA RELEASE] All Levels of Society Must Comply with SOPs – AMM

The Academy of Medicine of Malaysia (AMM) urged the government to enforce mandatory quarantine in designated quarantine centres for Sabah returnees. It has been proven in other countries, such as China and Singapore where compliance rates are high, that home quarantines are not as effective in curbing spread.

[Q&A] COVID-19: What is a Super Spreader?

The latest Sivagangga cluster from Kedah was suspected of being caused by a super spreader strain of the COVID-19 virus that originated from Egypt and Pakistan. Health authorities believed there is a high probability that the cluster is a super spreader because of its higher transmission rate compared to previous COVID-19 clusters. We spoke to Associate Prof. Dr Chan Yoke Fun, Virologist & Senior Lecturer at the Department of Medical Microbiology, Faculty of Medicine, University of Malaya to learn more.

[MEDIA RELEASE] WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19

These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect.

[OPINION] Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?

As of 12 May 2020, 4,425,094 people have been infected with SARS-CoV-2 with deaths reaching 297,723.Doctors are desperately looking for an effective drug, and there have been a number of candidates on trial; one of them, remdesivir, is probably the most exciting of all. This is the drug developed for the Ebola epidemic in 2015, but it was found to be less effective in clinical trials than in in vitro studies. Is remdesivir the panacea for COVID-19?

[EXPERT REACTION] Dexamethasone: Effective Treatment for COVID-19?

A research team at Oxford University has recently found a cheap and widely available drug called dexamethasone that can be used to effectively treat severe forms of COVID-19. The 'breakthrough' drug has shown to significantly reduce the number of deaths among those seriously ill with the coronavirus. We asked experts to comment on the effectiveness of the drug in treating COVID-19.